• Home
  • News
  • Coins2Day 500
  • Tech
  • Finance
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
PoliticsU.S. Politics

Deal reached on bipartisan $8.3B bill to battle coronavirus

By
Andrew Taylor
Andrew Taylor
and
The Associated Press
The Associated Press
Down Arrow Button Icon
By
Andrew Taylor
Andrew Taylor
and
The Associated Press
The Associated Press
Down Arrow Button Icon
March 4, 2020, 1:56 PM ET

Capitol Hill negotiators have reached agreement on an $8.3 billion measure to battle the coronavirus outbreak  that’s spreading and threatening a major shock to the economy and disruptions to everyday life in the U.S.

The House will vote on the deal later Wednesday and Senate leaders are pressing for a vote in that chamber by the end of the week. The agreement was announced by spokespersons for the house and Senate Appropriations panels who negotiated the legislation.

The legislation came together in little more than a week, a rarity in a deeply polarized Washington. It triples the $2.5 billion plan unveiled by President Donald Trump just last week.

Trump, however, is sure to sign the measure, which has the blessing of top Republicans like Senate Majority Leader Mitch McConnell, R-Ky., and top House Republican Kevin McCarthy of California.

“This moment calls for collaboration and unity,” McConnell said. “It’s time to give our public health experts and healthcare professionals the surge resources they need at this challenging time.”

The agreement came together after House Speaker Nancy Pelosi, D-Calif., dropped a demand, opposed by the drug industry, to guarantee that any vaccines and drug treatments developed with government-backed research — but manufactured by drug companies — be offered at “affordable” prices.

Instead, the agreement provides $300 million for the government to purchase such drugs at “fair and reasonable” prices to distribute them to those who need it — which is the standard applied in earlier crises like the 2009 H1N1 flu outbreak.

The bipartisan legislation includes: $350 million to aggressively go after the virus in “hot spots” like Washington state; $500 million to buy drugs, masks, and other medical supplies for states, local governments and hospitals; $1 billion to reimburse state and local governments for costs incurred in battling the outbreak; and $300 million for the Centers for Disease Control’s rapid response fund.

More than $800 million would fund research into a vaccine, improved tests, and drugs to treat infected people. Another $1.3 billion would be used to help fight the virus overseas.

The agreement comes as the outbreak in the U.S. Appears increasingly likely to affect workers who are instructed to stay home, immigrants who may fear seeking treatment because they are in the U.S. Illegally, and the potential rapid spread among homeless people. Widespread school closures are possible as well.

Vice President Mike Pence, who is coordinating the administration’s response, is returning to Capitol Wednesday afternoon to separately brief House Democrats and Republicans.

Also Wednesday, top congressional leaders are meeting to discuss what additional steps may be needed to ensure the safety of the Capitol complex — for lawmakers and staff, as well as the annual influx of visitors this spring.

More must-read stories from Coins2Day:

—Are we undergoing an industrial revolution or a phase change?
—Twitter’s testing new ways to fight misinformation. Is open-source the answer?
—Meet Trump’s Giuliani-approved power broker—and Melania’s new senior adviser
—Angela Merkel is on her way out. Meet her potential replacements
—How the 2020 election could influence your personal finances

Get up to speed on your morning commute with Coins2Day’s CEO Daily newsletter.

About the Authors
By Andrew Taylor
See full bioRight Arrow Button Icon
By The Associated Press
See full bioRight Arrow Button Icon
Rankings
  • 100 Best Companies
  • Coins2Day 500
  • Global 500
  • Coins2Day 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Coins2Day Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Coins2Day Brand Studio
  • Coins2Day Analytics
  • Coins2Day Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Coins2Day
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map

© 2025 Coins2Day Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Coins2Day Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.